首頁 > 市場調查報告書 > 製藥

動物用醫藥

市場調查報告書

商品編碼

1922713

日本獸藥市場規模、佔有率、趨勢及預測（依產品類型、動物種類、給藥途徑、通路及地區分類，2026-2034年）

Japan Veterinary Medicine Market Size, Share, Trends and Forecast by Product, Animal Type, Route of Administration, Distribution Channel, and Region, 2026-2034

出版日期: 2026年01月01日 | 出版商:

IMARC | 英文 118 Pages | 商品交期: 5-7個工作天內

價格

簡介目錄

日本動物醫藥市場在2025年達到23億美元。 IMARC Group預測，到2034年，該市場規模將達到37億美元，2026年至2034年的複合年成長率為5.22%。推動日本動物醫藥市場成長的主要因素包括寵物飼養數量的增加、動物健康意識的提高、對伴侶動物照護需求的成長、獸醫院數量的增加、政府對牲畜疾病預防的支持以及藥物製劑技術的進步。

日本動物醫藥市場趨勢：

伴侶動物數量和支出增加

在日本，寵物擬人化趨勢正在穩步推進，越來越多的人將寵物視為家庭成員，並接納它們進入家中。根據業界報告顯示，截至2023年，約有21%的日本受訪者擁有寵物，其中犬貓佔寵物總數的28.1%。這表明寵物在日本家庭中佔據重要地位，並在推動日本動物醫藥市場成長方面發揮重要作用。犬貓的高比例也支撐了對特定物種藥物和獸醫服務的持續需求。在都市區，單身家庭的增加和人口老化是推動寵物需求的關鍵因素。在人口密集的城市，社會孤立現象特別普遍，而寵物能夠提供情感支持和陪伴。這種人口結構的變化導致每隻寵物就診次數增加，並顯著擴大了疫苗接種、寄生蟲防治和牙科治療等預防性護理的需求。為此，製藥公司正在擴大其針對犬貓的藥品產品線，目前已包括治療皮膚病、消化系統疾病和心臟疾病的藥物。

擴大獸醫基礎設施和技術

日本的獸醫服務正透過臨床基礎設施的現代化和數位技術的整合而不斷發展。獸醫診所擴大採用診斷影像設備、電子健康記錄和先進的手術器械，提高了動物醫療保健的精確度和覆蓋範圍，這對日本獸醫市場的前景產生了積極影響。這一趨勢在大都會圈尤其明顯，聚集了多家獸醫診所和專科醫院。此外，對包括寵物遠距醫療在內的數位遠端醫療平台的投資也在不斷成長。這使得遠距諮詢和後續觀察護理成為可能，這對老年寵物飼主和居住在難以獲得面對面醫療服務的農村地區的寵物主人尤其重要。此外，診斷實驗室正在擴展其基因檢測、抗菌素抗藥性篩檢和早期疾病檢測等服務，這些服務目前在小型動物診所中的應用也越來越廣泛。基礎設施的這些發展為不斷擴充的藥品種類和更高的處方治療依從性提供了支持。

重點在於畜禽疾病控制和生物安全

由於日本高度依賴畜產品，且需要預防諸如豬瘟和禽流感等疫情的爆發，該國高度重視畜牧業疾病控制和生物安全。此外，政府政策和資金支持措施持續推動全國疾病監測系統、疫苗接種計畫和緊急應變通訊協定的實施。農林水產省積極與當地獸醫機構和製藥公司合作，以確保獸用生技藥品和治療藥物的穩定供應。同時，畜牧業對抗菌藥物的合理使用日益關注，促使精準醫療方法得以應用，即根據病原體特異性數據調整用藥方案。隨著畜牧業向永續性和國際合規標準邁進，製藥公司正在開發傳統抗生素的替代品，進一步擴大在日本動物醫藥的佔有率。

本報告解答的關鍵問題

日本動物醫藥市場目前發展狀況如何？您認為未來幾年它將如何發展？
日本動物用藥品市場依產品分類的組成是什麼？
日本動物醫藥市場依動物種類分類的組成是怎樣的？
日本動物醫藥市場依給藥途徑分類的市場組成為何？
日本動物用藥品市場按通路的組成是怎樣的？
日本獸藥市場按地區分類的市場區隔如何？
請介紹一下日本獸藥價值鏈的各個環節。
日本動物醫藥市場的主要促進因素和挑戰是什麼？
日本動物用藥品市場的結構是怎麼樣的？主要參與者有哪些？
日本獸藥市場的競爭程度如何？

The Japan veterinary medicine market size reached USD 2.30 Billion in 2025 . Looking forward, IMARC Group expects the market to reach USD 3.70 Billion by 2034 , exhibiting a growth rate (CAGR) of 5.22% during 2026-2034 . The rising pet ownership, growing awareness of animal health, increasing demand for companion animal care, expansion of veterinary clinics, government support for livestock disease control, and advancements in pharmaceutical formulations are some of the key factors driving the veterinary medicine market in Japan.

JAPAN VETERINARY MEDICINE MARKET TRENDS:

Growth in Companion Animal Ownership and Expenditure

Japan is witnessing a steady shift toward pet humanization, with households increasingly adopting companion animals and treating them as family members. According to industry reports, approximately 21% of respondents in Japan reported owning pets, with cats and dogs making up 28.1% of the total pet population in 2023. This highlights the strong presence of companion animals in Japanese households and their significant role in propelling the Japan veterinary medicine market growth. The high proportion of cats and dogs underscores a sustained demand for species-specific pharmaceutical products and veterinary services. In urban regions, the rise of single-person households and the growing elderly population are key factors driving the demand for companion animals. Pets offer emotional support and companionship, especially in densely populated cities where social isolation is more prevalent. This demographic trend is contributing to higher veterinary visits per animal and a notable rise in preventative treatments such as vaccinations, parasite control, and dental care. Pharmaceutical companies are responding by expanding their portfolio of canine and feline medications, which now include therapies for dermatological issues, gastrointestinal conditions, and cardiac care.

Expansion of Veterinary Clinical Infrastructure and Technology

The veterinary services landscape in Japan is evolving through the modernization of clinical infrastructure and the integration of digital technologies. Veterinary clinics are increasingly adopting diagnostic imaging tools, electronic medical records, and advanced surgical equipment to enhance the accuracy and scope of animal healthcare, which is positively impacting Japan veterinary medicine market outlook. This trend is particularly visible in larger urban centers where multi-veterinarian practices and specialty hospitals are becoming more common. In addition to this, increasing investment in digital health platforms, including telemedicine for pets, is also gaining traction. This enables remote consultations and post-treatment monitoring, which is particularly important for aging pet owners or rural communities with limited access to in-person veterinary services. Additionally, diagnostic laboratories are expanding their offerings to include genetic testing, antimicrobial resistance screening, and early disease detection panels, which are now being used more regularly in small animal practices. This infrastructural development supports a broader pharmaceutical product range and higher compliance with prescribed treatments.

Focus on Livestock Disease Management and Biosecurity

Japan places strong regulatory emphasis on livestock disease control and biosecurity, driven by its high dependence on domestic animal products and a need to prevent outbreaks such as swine fever and avian influenza. Moreover, government policies and funding initiatives continue to support the nationwide implementation of disease surveillance systems, vaccination programs, and emergency response protocols. The Ministry of Agriculture, Forestry, and Fisheries (MAFF) actively collaborates with regional veterinary services and pharmaceutical companies to ensure a consistent supply of veterinary biologicals and therapeutics. Additionally, there is growing attention to antimicrobial stewardship in livestock. This is driving the adoption of precision medicine approaches, where drug administration is tailored to pathogen-specific data. As the sector moves toward sustainability and international compliance standards, veterinary pharmaceutical companies are developing alternatives to conventional antibiotics, which is further augmenting Japan veterinary medicine market share.

JAPAN VETERINARY MEDICINE MARKET SEGMENTATION:

Product Insights:

Drugs Anti-infective Anti-inflammatory Parasiticide
Anti-infective
Anti-inflammatory
Parasiticide
Vaccines Inactivated Vaccines Attenuated Vaccines Recombinant Vaccines
Inactivated Vaccines
Attenuated Vaccines
Recombinant Vaccines
Medicated Feed Additives Amino Acids Antibiotics
Amino Acids
Antibiotics
Drugs Anti-infective Anti-inflammatory Parasiticide
Anti-infective
Anti-inflammatory
Parasiticide
Anti-infective
Anti-inflammatory
Parasiticide
Anti-infective
Anti-inflammatory
Parasiticide
Vaccines Inactivated Vaccines Attenuated Vaccines Recombinant Vaccines
Inactivated Vaccines
Attenuated Vaccines
Recombinant Vaccines
Inactivated Vaccines
Attenuated Vaccines
Recombinant Vaccines
Inactivated Vaccines
Attenuated Vaccines
Recombinant Vaccines
Medicated Feed Additives Amino Acids Antibiotics
Amino Acids
Antibiotics
Amino Acids
Antibiotics
Amino Acids
Antibiotics

Animal Type Insights:

Production
Companion
Production
Companion

Route of Administration Insights:

Oral
Parenteral
Topical
Oral
Parenteral
Topical

Distribution Channel Insights:

Veterinary Hospitals and Clinics
Point-of-Care Testing/In-house Testing
Others
Veterinary Hospitals and Clinics
Point-of-Care Testing/In-house Testing
Others

Regional Insights:

Kanto Region
Kansai/Kinki Region
Central/ Chubu Region
Kyushu-Okinawa Region
Tohoku Region
Chugoku Region
Hokkaido Region
Shikoku Region
Kanto Region
Kansai/Kinki Region
Central/ Chubu Region
Kyushu-Okinawa Region
Tohoku Region
Chugoku Region
Hokkaido Region
Shikoku Region
The report has also provided a comprehensive analysis of all the major regional markets, which include Kanto Region, Kansai/Kinki Region, Central/ Chubu Region, Kyushu-Okinawa Region, Tohoku Region, Chugoku Region, Hokkaido Region, and Shikoku Region.

COMPETITIVE LANDSCAPE:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

KEY QUESTIONS ANSWERED IN THIS REPORT
How has the Japan veterinary medicine market performed so far and how will it perform in the coming years?
What is the breakup of the Japan veterinary medicine market on the basis of product?
What is the breakup of the Japan veterinary medicine market on the basis of animal type?
What is the breakup of the Japan veterinary medicine market on the basis of route of administration?
What is the breakup of the Japan veterinary medicine market on the basis of distribution channel?
What is the breakup of the Japan veterinary medicine market on the basis of region?
What are the various stages in the value chain of the Japan veterinary medicine market?
What are the key driving factors and challenges in the Japan veterinary medicine market?
What is the structure of the Japan veterinary medicine market and who are the key players?
What is the degree of competition in the Japan veterinary medicine market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Japan Veterinary Medicine Market - Introduction

4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence

5 Japan Veterinary Medicine Market Landscape

5.1 Historical and Current Market Trends (2020-2025)
5.2 Market Forecast (2026-2034)

6 Japan Veterinary Medicine Market - Breakup by Product

6.1 Drugs
- 6.1.1 Overview
- 6.1.2 Historical and Current Market Trends (2020-2025)
- 6.1.3 Market Segmentation
  - 6.1.3.1 Anti-infective
  - 6.1.3.2 Anti-inflammatory
  - 6.1.3.3 Parasiticide
- 6.1.4 Market Forecast (2026-2034)
6.2 Vaccines
- 6.2.1 Overview
- 6.2.2 Historical and Current Market Trends (2020-2025)
- 6.2.3 Market Segmentation
  - 6.2.3.1 Inactivated Vaccines
  - 6.2.3.2 Attenuated Vaccines
  - 6.2.3.3 Recombinant Vaccines
- 6.2.4 Market Forecast (2026-2034)
6.3 Medicated Feed Additives
- 6.3.1 Overview
- 6.3.2 Historical and Current Market Trends (2020-2025)
- 6.3.3 Market Segmentation
  - 6.3.3.1 Amino Acids
  - 6.3.3.2 Antibiotics
- 6.3.4 Market Forecast (2026-2034)

7 Japan Veterinary Medicine Market - Breakup by Animal Type

7.1 Production
- 7.1.1 Overview
- 7.1.2 Historical and Current Market Trends (2020-2025)
- 7.1.3 Market Forecast (2026-2034)
7.2 Companion
- 7.2.1 Overview
- 7.2.2 Historical and Current Market Trends (2020-2025)
- 7.2.3 Market Forecast (2026-2034)

8 Japan Veterinary Medicine Market - Breakup by Route of Administration

8.1 Oral
- 8.1.1 Overview
- 8.1.2 Historical and Current Market Trends (2020-2025)
- 8.1.3 Market Forecast (2026-2034)
8.2 Parenteral
- 8.2.1 Overview
- 8.2.2 Historical and Current Market Trends (2020-2025)
- 8.2.3 Market Forecast (2026-2034)
8.3 Topical
- 8.3.1 Overview
- 8.3.2 Historical and Current Market Trends (2020-2025)
- 8.3.3 Market Forecast (2026-2034)

9 Japan Veterinary Medicine Market - Breakup by Distribution Channel

9.1 Veterinary Hospitals and Clinics
- 9.1.1 Overview
- 9.1.2 Historical and Current Market Trends (2020-2025)
- 9.1.3 Market Forecast (2026-2034)
9.2 Point-of-Care Testing/In-house Testing
- 9.2.1 Overview
- 9.2.2 Historical and Current Market Trends (2020-2025)
- 9.2.3 Market Forecast (2026-2034)
9.3 Others
- 9.3.1 Historical and Current Market Trends (2020-2025)
- 9.3.2 Market Forecast (2026-2034)

10 Japan Veterinary Medicine Market - Breakup by Region

10.1 Kanto Region
- 10.1.1 Overview
- 10.1.2 Historical and Current Market Trends (2020-2025)
- 10.1.3 Market Breakup by Product
- 10.1.4 Market Breakup by Animal Type
- 10.1.5 Market Breakup by Route of Administration
- 10.1.6 Market Breakup by Distribution Channel
- 10.1.7 Key Players
- 10.1.8 Market Forecast (2026-2034)
10.2 Kansai/Kinki Region
- 10.2.1 Overview
- 10.2.2 Historical and Current Market Trends (2020-2025)
- 10.2.3 Market Breakup by Product
- 10.2.4 Market Breakup by Animal Type
- 10.2.5 Market Breakup by Route of Administration
- 10.2.6 Market Breakup by Distribution Channel
- 10.2.7 Key Players
- 10.2.8 Market Forecast (2026-2034)
10.3 Central/ Chubu Region
- 10.3.1 Overview
- 10.3.2 Historical and Current Market Trends (2020-2025)
- 10.3.3 Market Breakup by Product
- 10.3.4 Market Breakup by Animal Type
- 10.3.5 Market Breakup by Route of Administration
- 10.3.6 Market Breakup by Distribution Channel
- 10.3.7 Key Players
- 10.3.8 Market Forecast (2026-2034)
10.4 Kyushu-Okinawa Region
- 10.4.1 Overview
- 10.4.2 Historical and Current Market Trends (2020-2025)
- 10.4.3 Market Breakup by Product
- 10.4.4 Market Breakup by Animal Type
- 10.4.5 Market Breakup by Route of Administration
- 10.4.6 Market Breakup by Distribution Channel
- 10.4.7 Key Players
- 10.4.8 Market Forecast (2026-2034)
10.5 Tohoku Region
- 10.5.1 Overview
- 10.5.2 Historical and Current Market Trends (2020-2025)
- 10.5.3 Market Breakup by Product
- 10.5.4 Market Breakup by Animal Type
- 10.5.5 Market Breakup by Route of Administration
- 10.5.6 Market Breakup by Distribution Channel
- 10.5.7 Key Players
- 10.5.8 Market Forecast (2026-2034)
10.6 Chugoku Region
- 10.6.1 Overview
- 10.6.2 Historical and Current Market Trends (2020-2025)
- 10.6.3 Market Breakup by Product
- 10.6.4 Market Breakup by Animal Type
- 10.6.5 Market Breakup by Route of Administration
- 10.6.6 Market Breakup by Distribution Channel
- 10.6.7 Key Players
- 10.6.8 Market Forecast (2026-2034)
10.7 Hokkaido Region
- 10.7.1 Overview
- 10.7.2 Historical and Current Market Trends (2020-2025)
- 10.7.3 Market Breakup by Product
- 10.7.4 Market Breakup by Animal Type
- 10.7.5 Market Breakup by Route of Administration
- 10.7.6 Market Breakup by Distribution Channel
- 10.7.7 Key Players
- 10.7.8 Market Forecast (2026-2034)
10.8 Shikoku Region
- 10.8.1 Overview
- 10.8.2 Historical and Current Market Trends (2020-2025)
- 10.8.3 Market Breakup by Product
- 10.8.4 Market Breakup by Animal Type
- 10.8.5 Market Breakup by Route of Administration
- 10.8.6 Market Breakup by Distribution Channel
- 10.8.7 Key Players
- 10.8.8 Market Forecast (2026-2034)

11 Japan Veterinary Medicine Market - Competitive Landscape

11.1 Overview
11.2 Market Structure
11.3 Market Player Positioning
11.4 Top Winning Strategies
11.5 Competitive Dashboard
11.6 Company Evaluation Quadrant

12 Profiles of Key Players

12.1 Company A
- 12.1.1 Business Overview
- 12.1.2 Products Offered
- 12.1.3 Business Strategies
- 12.1.4 SWOT Analysis
- 12.1.5 Major News and Events
12.2 Company B
- 12.2.1 Business Overview
- 12.2.2 Products Offered
- 12.2.3 Business Strategies
- 12.2.4 SWOT Analysis
- 12.2.5 Major News and Events
12.3 Company C
- 12.3.1 Business Overview
- 12.3.2 Products Offered
- 12.3.3 Business Strategies
- 12.3.4 SWOT Analysis
- 12.3.5 Major News and Events
12.4 Company D
- 12.4.1 Business Overview
- 12.4.2 Products Offered
- 12.4.3 Business Strategies
- 12.4.4 SWOT Analysis
- 12.4.5 Major News and Events
12.5 Company E
- 12.5.1 Business Overview
- 12.5.2 Products Offered
- 12.5.3 Business Strategies
- 12.5.4 SWOT Analysis
- 12.5.5 Major News and Events

13 Japan Veterinary Medicine Market - Industry Analysis

13.1 Drivers, Restraints, and Opportunities
- 13.1.1 Overview
- 13.1.2 Drivers
- 13.1.3 Restraints
- 13.1.4 Opportunities
13.2 Porters Five Forces Analysis
- 13.2.1 Overview
- 13.2.2 Bargaining Power of Buyers
- 13.2.3 Bargaining Power of Suppliers
- 13.2.4 Degree of Competition
- 13.2.5 Threat of New Entrants
- 13.2.6 Threat of Substitutes
13.3 Value Chain Analysis